ZYCEVA 100MG TABS

Product Description

• Active Ingredient: Erlotinib 100 mg.
• Mechanism of Action: The medication works by blocking the action of an abnormal protein called the epidermal growth factor receptor (EGFR), which is found on the surface of cancer cells and helps them grow and multiply. By inhibiting this protein, Zyceva helps slow the growth and spread of cancer cells.
• Uses:
  • Non-small cell lung cancer (NSCLC): Used in patients with specific EGFR gene mutations, either as an initial therapy or after prior chemotherapy treatments.
  • Pancreatic cancer: Used in combination with another cancer medicine, gemcitabine, to manage cancer that has spread to other parts of the body (metastatic stage).
• Administration: The tablet is taken orally, usually once daily on an empty stomach (at least one hour before or two hours after a meal). It should be swallowed whole with water and not crushed or chewed.